To establish a deficit-neutral reserve fund relating to ending price gouging on prescription drugs.

SA 1207. Mr. MERKLEY proposed an amendment to the concurrent
resolution S. Con. Res. 7, setting forth the congressional budget for
the United States Government for fiscal year 2025 and setting forth the
appropriate budgetary levels for fiscal years 2026 through 2034; as
follows:

At the end of title III, add the following:

SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO REDUCING
FEDERAL HEALTH PROGRAM SPENDING FOR
PRESCRIPTION DRUGS.

The Chairman of the Committee on the Budget of the Senate
may revise the allocations of a committee or committees,
aggregates, and other appropriate levels in this resolution,
and make adjustments to the pay-as-you-go ledger, for one or
more bills, joint resolutions, amendments, amendments between
the Houses, motions, or conference reports relating to
reducing health care costs, which may include legislation
enabling Americans to have a much improved opportunity to
purchase prescription drugs at, or near, the lower prices
manufacturers charge in other similarly developed nations,
requiring pharmaceutical manufacturers to report annually the
amount of taxpayer dollars used to benefit manufacturers'
research and development efforts, or enacting other
mechanisms to purchase prescription drugs at lower prices, by
the amounts provided in such legislation for those purposes,
provided that such legislation would not increase the deficit
over the period of the total of fiscal years 2025 through
2034.
______